CompletedPhase 3

Babesia Testing in Blood Donors

United States90,116 participantsStarted 2011-12

Plain-language summary

Both prospective and retrospective (look back) study of blood donors for laboratory evidence of babesia microti infection. Two laboratory methodologies will be utilized: 1. \- PCR, to look for the presence of B.microti in whole blood 2. \- IFA, to look for significant titers of B.microti antibody

Who can participate

Age range16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * same as for donating blood Exclusion Criteria: * donor refusual to sign informed consent for this investigational babesia testing

What they're measuring

number of blood donors testing positive for evidence of Babesia infection

Timeframe: goal is up to one year (all specimens by end 2012)

Trial details

NCT IDNCT01528449

SponsorImugen

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2014-09

View on ClinicalTrials.gov More Transfusion Transmitted Babesiosis trials